Benzodiazepine exposure in pregnancy does not up risk for ADHD, autism
Benzodiazepine exposure during pregnancy seems not to be associated with increased risks for development of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), according to a study published online Nov. 22 in JAMA Network Open.
Other Articles in this Edition
Adderall shortage raises questions about widespread dependency on the drug
How to Tell the Difference Between Regular Distraction and A.D.H.D.
Concerns grow over online ADHD diagnoses
Simulated driving program reduces crash risk for teens with ADHD in small study
NIH researchers unlock pattern of gene activity for ADHD
Benzodiazepine exposure in pregnancy does not up risk for ADHD, autism
Methylphenidate Improves Functionality in Preschoolers With ADHD
Young Motherhood, Child ADHD Link Explained
Teens and young adults are self-diagnosing mental illness on TikTok. What could go wrong?
Amid the Adderall Shortage, People With A.D.H.D. Face Withdrawal and Despair